PeptideKey News
China makes 80% of thymosin alpha-1. New MOFCOM export licensing made the molecule political — exactly as a US Phase 2 long-COVID trial begins dosing.
This article is part of PeptideKey's evidence-based peptide research library covering 100+ compounds with lab-verified purity data.